Carlo Chiesa
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry (NCT05299437) | Carlo Chiesa | 2021-05-12 |
Track Carlo Chiesa automatically
Every clearance here is in the API, with alerts when new ones post.